apr 14, 2014 - FDA finalized the proposed class-wide safety
labeling changes for all extended-release and
long-acting (ER/LA) opioid analgesics, and
responded to two citizen petitions regarding
labeling for neonatal opioid withdrawal syndrome
(NOWS).
